Drug Profile
Research programme: conjugated monoclonal antibodies - SOTIO
Alternative Names: ICKs; Immunocytokines - SOTIO; LCB-20ALatest Information Update: 26 Nov 2021
Price :
$50
*
At a glance
- Originator Cytune Pharma
- Developer Cytune Pharma; SOTIO
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Solid tumours
- No development reported Cancer
Most Recent Events
- 16 Nov 2021 SOTIO Biotech in-licenses ConjuAll™ antibody-drug conjugate technology from LegoChem Biosciences to develop antibody-drug conjugates for Solid tumours
- 16 Nov 2021 Early research in Solid tumours in Czech Republic (Parenteral)
- 30 Aug 2018 Cytune Pharma has been acquired and merged into SOTIO